Immunohistochemical indices of some types of hormones among benign tumors of the salivary glands

August 30, 2019
966
Resume

Immunohistochemistry (IHC) in the diagnosis of salivary glands (SG) tumors remains the gold standard for final verification of tumors, along with pathomorphological examination of the resectatum. The most prominent markers are various types of human papillomavirus, cytomegaloviruses, Epstein — Barr virus, progesterone (PR), estrogen (ER), androgen (AR) receptors, various cytokeratins to confirm tumors malignancy. The majority of recent works devoted to presence and possibility of endocrine regulation influence on SG tumors tissues testify to presence of PR, ER, AR. Their amount in SG tumors tissues is quite diverse and depends on geographical population. Objective — to study the amount of PR, ER in SG tumors tissues by IHC. Materials and methods. Histologic typing of SG tumors was performed using routine coloration with hematoxylin and eosin and IHC. The study was conducted based on excisional biopsy of SG (pleomorphic adenoma and adenolymphomas) in 32 patients. IHC was performed with Monoclonal Rabbit antibody Anti-Human ER («Dako IS 151», Denmark), Monoclonal Mouse antibody Anti-Human PR («Dako IR068», Denmark) using «EnVisionTM FLEX Detection System» («Dako», Denmark). For positive control tissue samples with definite positive reactivity were used, for negative — the procedure was performed without the use of primary antibodies. Results. Data analysis showed that all patients with pleomorphic adenomas had only parotid SG affected. Among the hormones present in the tissues of parotid SG tumor 3 (10.7%) is progesterone, 2 (7.14%) is estrogen. Hormones indicators of estrogen dominated among SG adenolymphomas — 3 (75%). Conclusions. SG benign tumors (pleomorphic adenomas and adenolymphomas) are characteristic of ER and PR expression. Tumors localized in parotid SG in all patients demonstrating positive reactions to expression of ER and PR.

Published: 30.08.2019
References:

  • Actis A.B. (2005) A hypothesis to relate salivary tumors with mammary and prostate neoplasias. Bioinformation, 1(1): 12–13.
  • Aquino G., Collina F., Sabatino R. et al. (2018) Sex hormone receptors in benign and malignant salivary gland tumors: prognostic and predictive role. Int. J. Mol. Sci.,19(2): 399.
  • Can N.T., Lingen M.W., Mashek H. et al. (2018) Expression of hormone receptors and HER-2 in benign and malignant salivary gland tumors. Head Neck Pathol., 12(1): 95–104.
  • Ito F.A., Coletta R.D., Vargas P.A., Lopes M.A. (2009) Immunohistochemical study of androgen, estrogen and progesterone receptors in salivary gland tumors. Braz. Oral. Res., 23(4): 393–398.
  • Kolude B., Adisa A., Adeyemi B., Lawal A. (2013) Immunohistochemical expression of oestrogen receptor-α and progesterone receptor in salivary gland tumours. J. Oral. Pathol. Med., 42(9): 716–719.
  • Lin F.C., Chen P.L., Tsao T.Y. et al. (2014) Prevalence of human papillomavirus and Epstein–Barr virus in salivary gland diseases. J. Int. Med. Res., 42(5): 1093–1101.
  • Nasser S.M., Faquin W.C., Dayal Y. (2003) Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am. J. Clin. Pathol., 119(6): 801–806.
  • Ozono S., Onozuka M., Sato K., Ito Y. (1992) Immunohistochemical localization of estradiol, progesterone, and progesterone receptor in human salivary glands and salivary adenoid cystic carcinomas. Cell Struct. Funct.,17(3): 169–175.
  • Prichard J.W. (2014) Overview of automated immunohistochemistry. Arch. Pathol. Lab. Med., 138(12): 1578–1582.
  • Tarakji B., Kujan O. (2012) Expression of oestrogen progestrone and androgen receptors in salivary gland tumours. A review of literature. Gulf. J. Oncolog., 11: 50–59.
  • Teymoortash A., Lippert B.M., Werner J.A. (2001) Steroid hormone receptors in parotid gland cystadenolymphoma (Warthin’s tumour). Clin. Otolaryngol. Allied. Sci., 26(5): 411–416.